Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vaccine to pathogenic immune activation cells during infections

Vaccine to pathogenic immune activation cells during infections

US Patent 10632186 · Granted Apr 28, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of inhibiting HIV-1 viral rebound in a subject using interferon inhibitor2024
Vaccine to pathogenic immune activation cells during infections2024
Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cells and therap2022
Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic uses thereof2021
Vaccine to pathogenic immune activation cells during infections2021
Stable immunogenic product comprising antigenic heterocomplexes2014
High-yield method for the production of human antibodies blocking the biological2014
Method for preparing a stable TNF-α vaccine2013
Use of immunogens to treat or prevent, in malignant tumors, the immune or vascul2012
Stable immunogenic product comprising antigenic heterocomplexes2011
Method for preparing a stable immunogenic product comprising antigenic heterocom2011
Use of immunogenic immunosuppressive and/or angiogenic proteins which have been 2009